Send us a Message



Submit Data |  Help |  Video Tutorials |  News |  Publications |  Download |  REST API |  Citing RGD |  Contact   

CLINICAL MEASUREMENT - ANNOTATIONS

The Clinical Measurement Ontology (CMO), Measurement Methods Ontology (MMO), and Experimental Condition Ontology (XCO) are currently being developed at the Rat Genome Database. For more information about these vocabularies please see Shimoyama et al. Three ontologies to define phenotype measurement data. Front Genet. 2012;3:87. Epub 2012 May 28 or contact us (http://rgd.mcw.edu/contact/index.shtml).

Term:percentage of study population developing chronic experimental autoimmune encephalomyelitis during a period of time
go back to main search page
Accession:CMO:0001893 term browser browse the term
Definition:The number of new cases of chronic experimental autoimmune encephalomyelitis (EAE) appearing in a study population during a certain period compared to the total number of individuals in the study population, expressed as a percentage. EAE is an animal model of brain inflammation in which inflammation is induced through immunization of the animal with central nervous system antigens or by the passive transfer of autoreactive T cells. Chronic EAE is a variant of EAE characterized by a long duration and slow, constant progression.
Comment:For disease characterized by repeated symptomatic attacks followed by complete or almost complete improvement, use the term for relapsing-remitting experimental autoimmune encephalomyelitis.
Synonyms:related_synonym: chronic EAE incidence;   percentage of study population developing chronic EAE during a period of time



show annotations for term's descendants           Sort by:

Term paths to the root
Path 1
Term Annotations click to browse term
  clinical measurement 2369
    disease population measurement 57
      disease incidence/prevalence measurement 57
        nervous system disease incidence/prevalence measurement 25
          experimental autoimmune encephalomyelitis incidence/prevalence measurement 16
            percentage of study population developing experimental autoimmune encephalomyelitis during a period of time 7
              percentage of study population developing chronic experimental autoimmune encephalomyelitis during a period of time 0
paths to the root